Bifenthrin

Bifenthrin

SCHEMBL14191222

Cc1c(COC(=O)[C@H]2[C@@H](/C=C(/Cl)C(F)(F)F)C2(C)C)cccc1-c1ccccc1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
LMNA P02545 2/20 0.50
ADRA2A P08913 1/20 0.50
CNR1 P21554 1/20 0.50
ATM Q13315 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
EPHX1 P07099 2/20 0.42
CD274 Q9NZQ7 11/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
PDCD1 Q15116 3/20 0.39
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bifenthrin SCHEMBL5050463 1.00 TDP1 (0.59) TDP1MEN1KMT2ALMNAADRA2A
Bifenthrin SCHEMBL4331886 1.00 TDP1 (0.59) TDP1MEN1KMT2ALMNAADRA2A
Bifenthrin SCHEMBL22467 1.00 TDP1 (0.59) TDP1MEN1KMT2ALMNAADRA2A
Bifenthrin SCHEMBL22469 1.00 TDP1 (0.59) TDP1MEN1KMT2ALMNAADRA2A
Bifenthrin SCHEMBL11060417 1.00 TDP1 (0.59) TDP1MEN1KMT2ALMNAADRA2A
Bifenthrin SCHEMBL3805796 1.00 TDP1 (0.59) TDP1MEN1KMT2ALMNAADRA2A
Bifenthrin SCHEMBL8816345 1.00 TDP1 (0.59) TDP1MEN1KMT2ALMNAADRA2A
Bifenthrin SCHEMBL8769074 1.00 TDP1 (0.59) TDP1MEN1KMT2ALMNAADRA2A
Bifenthrin SCHEMBL3919515 1.00 TDP1 (0.59) TDP1MEN1KMT2ALMNAADRA2A
Bifenthrin SCHEMBL34465320 1.00 TDP1 (0.59) TDP1MEN1KMT2ALMNAADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9155306-B2 Methods for the production of granular composite pesticidal compositions and the compositions produced thereby OMS INVESTMENTS, INC. (US) 2015-10-13 US disclosed
US-9155306-B2 Methods for the production of granular composite pesticidal compositions and the compositions produced thereby OMS INVESTMENTS, INC. (US) 2015-10-13 US disclosed
US-20080103048-A1 Coating tackifying solution including a non-cyano containing pyrethrum insecticide dissolved in a non-polar solvent onto exterior surface of granular substrate; applying a small grain or powdered pesticide whereby tackifying solution causes adhesion; unitary formulation kills weeds and fire ants in lawns JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103048-A1 Coating tackifying solution including a non-cyano containing pyrethrum insecticide dissolved in a non-polar solvent onto exterior surface of granular substrate; applying a small grain or powdered pesticide whereby tackifying solution causes adhesion; unitary formulation kills weeds and fire ants in lawns NOTUM, ACHE, BCHE TDP1 1538/4885MEN1 1809/4885KMT2A 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.